Drugs / CAR-γδT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04796441 | Dec 2020 → Dec 2021 | acute myeloid leukemia | Hebei Senlang Biotechnology Inc., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-γδT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04796441 ↗ |
| Modality | Cell therapy | “universal CAR-γδT cell injection” NCT04796441 ↗ |